CYCLOSET Drug Patent Profile
✉ Email this page to a colleague
When do Cycloset patents expire, and when can generic versions of Cycloset launch?
Cycloset is a drug marketed by Veroscience and is included in one NDA. There are thirteen patents protecting this drug.
This drug has thirty-three patent family members in thirteen countries.
The generic ingredient in CYCLOSET is bromocriptine mesylate. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cycloset
A generic version of CYCLOSET was approved as bromocriptine mesylate by SANDOZ on January 13th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CYCLOSET?
- What are the global sales for CYCLOSET?
- What is Average Wholesale Price for CYCLOSET?
Summary for CYCLOSET
International Patents: | 33 |
US Patents: | 13 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Clinical Trials: | 9 |
Patent Applications: | 3,236 |
Drug Prices: | Drug price information for CYCLOSET |
What excipients (inactive ingredients) are in CYCLOSET? | CYCLOSET excipients list |
DailyMed Link: | CYCLOSET at DailyMed |


Recent Clinical Trials for CYCLOSET
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) | Phase 4 |
Dennis McNamara | Phase 4 |
Hospital General León | Phase 2/Phase 3 |
Pharmacology for CYCLOSET
Drug Class | Ergot Derivative |
US Patents and Regulatory Information for CYCLOSET
CYCLOSET is protected by one hundred and twenty-six US patents.
Expired US Patents for CYCLOSET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,468,755 | ⤷ Free Trial |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 8,137,993 | ⤷ Free Trial |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 8,137,992 | ⤷ Free Trial |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,866,584 | ⤷ Free Trial |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 7,888,310 | ⤷ Free Trial |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,679,685 | ⤷ Free Trial |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,716,957 | ⤷ Free Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CYCLOSET
See the table below for patents covering CYCLOSET around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2010256366 | ⤷ Free Trial | |
Japan | H1072372 | MEDICINE COMPRISING PROLACTIN-INHIBITING COMPOUND | ⤷ Free Trial |
World Intellectual Property Organization (WIPO) | 2013165902 | ⤷ Free Trial | |
South Africa | 9505683 | ⤷ Free Trial | |
Australia | 3134595 | ⤷ Free Trial | |
China | 102458376 | Combination of dopamine agonists plus first phase insulin secretagouges for treatment of metabolic disorders | ⤷ Free Trial |
Uruguay | 34776 | FORMULACIONES DE BROMOCRIPTINA | ⤷ Free Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Market Dynamics and Financial Trajectory for CYCLOSET
More… ↓